
The FDA Just Approved a New Blue Food Dye: This Is What It's Made Of
As the fourth color additive from natural sources approved by the FDA this year, gardenia (genipin) blue has been granted permission to be used in various foods. According to the administration, this blue dye comes from the fruit of the gardenia, a flowering evergreen. It can be used in hard and soft candy, sports drinks, ready-to-drink teas, flavored or enhanced non-carbonated water and fruit drinks and ades.
"This expedited timeline underscored our serious intent to transition away from petroleum-based synthetic dyes in the food supply, said FDA Commissioner Marty Makary in a news release. "Now, by expanding the palette of available colors derived from natural sources, food manufacturers have a variety of options available that will make it easier to end their use of petroleum-based dyes."
Gardenia (genipin) blue joins the red algae-based galdieria extract blue, butterfly pea flower extract and the white color calcium phosphate as 2025's new and approved natural food color additives.
MichelleHow is gardenia (genipin) blue made?
The FDA approved the use of gardenia (genipin) blue from a petition by the Gardenia Blue Interest Group (GBIG). According to the FDA's order, gardenia (genipin) blue is a dark purple or blue liquid made from the mature fruit of the Gardenia jasminoides Ellis plant with soy protein hydrolysate. Now, you may be thinking: Isn't soy an allergen? According to the GBIG, the soy protein allergens aren't expected to be detected in the final color additive because "unreacted protein hydrolysate is removed during manufacturing."
Because no soy protein allergens will be in the final product, the GBIG is asking to be exempt from food allergen labeling. The FDA is currently reviewing this petition.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
35 minutes ago
- Washington Post
Improve your gut health with our new Try This: Gut Check newsletter
The Washington Post's 'Try This' podcast has a new companion — the Try This: Gut Check newsletter. It's a five-part newsletter series that breaks down what science actually says about how to support gut health without stress, supplements or confusing trends. I'm Cristina Quinn, and I'll be exploring questions like: What's the deal with probiotics? Do fermented foods really help? How do you actually eat more fiber without overhauling your life? Can I throw quinoa on everything?!


Medscape
36 minutes ago
- Medscape
Bariatric Surgery: Who's Eligible Now?
This transcript has been edited for clarity. Bariatric surgery is a powerful tool for long-term weight loss, but it requires lifelong commitment to healthy eating, physical activity, supplements, and behavior change. When should you refer for bariatric surgery? The 2019 AACE/TOS/ASMBS guidelines recommend considering surgery for individuals with a BMI over 35 and at least one obesity-related condition — like type 2 diabetes, sleep apnea, or hypertension — or anyone with a BMI over also note that patients with a BMI from 30 to 34.9 and poorly controlled type 2 diabetes may be considered. The updated 2022 ASMBS guidelines recommend expanding eligibility to include a BMI over 30with weight-related conditions, especially for Asian populations who experience metabolic risk at lower most insurance plans still only cover surgery for a BMI over 35 with associated conditions or a BMI over 40. Because long-term weight loss is difficult due to biologic adaptations, I offer surgery as an option to all eligible patients so they can make an informed choice. Surgery may be especially appropriate for patients who prefer surgery over lifelong obesity medications — though they'll still need lifelong vitamin supplementation — those who have not achieved long-term success with lifestyle interventions and/or obesity medications, or those who have higher BMI, for whom obesity medications and lifestyle modifications may not be sufficient to lead to resolution of weight-related complications. Importantly, this does not have to be an either/or patients benefit from a combination of bariatric surgery and obesity medications to achieve meaningful, lasting weight loss and improvements in health. As always, shared decision making is key, including a clear discussion of risks, benefits, alternatives, and patient goals.


Health Line
an hour ago
- Health Line
Olivia Munn's Mom Also Had Breast Cancer, Highlighting Genetic Risks
Olivia Munn recently shared her mother was also diagnosed with breast cancer. The actress has been open about her breast cancer journey and revealed that her mom, Kim Munn, took the same risk assessment test. Understanding your family history and other genetic risk factors for breast cancer could be lifesaving. Olivia Munn has been open about her breast cancer journey since being diagnosed in 2024. The actress and activist recently shared that her mother, Kim Munn, had also been diagnosed after taking the same risk assessment test she credits with saving her life. The actress, 45, shared her mother's diagnosis in an Instagram post on July 9. 'You may know that when I talk about my own battle with cancer I bring up the Lifetime Risk Assessment test that saved my life. I never would've predicted it would save my mom's life as well,' Olivia Munn wrote in the caption. Olivia Munn was diagnosed with Luminal B breast cancer in both breasts. Because this form of breast cancer can be aggressive, the 'Your Friends and Neighbors' star underwent a double mastectomy. She also had a hysterectomy, which removed her uterus, and a bilateral salpingo-oophorectomy, which is the removal of both ovaries and fallopian tubes. Both procedures can help prevent cancer recurrence. Now, her mother's breast cancer diagnosis highlights the importance of genetic risk factors in breast cancer and the importance of screening and genetic testing, particularly for the BRCA gene. Around 5–10% of all breast cancer cases are associated with people who have a family history of the disease. '[Genetic] tests look at the genes you were born with; therefore, one test will be truly lifelong,' said Louise Morrell, MD, medical oncologist and chief medical executive at the Lynn Cancer Institute, part of Baptist Health South Florida. Healthline recently spoke with Morrell to learn more about genetic risk factors influencing the risk for breast and other types of cancer, and the importance of genetic testing. This interview has been edited and condensed for clarity and brevity. How does family history contribute to cancer risk? Morrell: There are very powerful genetic mutations that cause a high risk of breast cancer, known as BRCA genes. These occur in about 3-4 out of 1,000 [people] and account for only 5% of all breast cancers. There are also less potent cancer genes that contribute to breast cancer at a much lower rate, which are found in about 10% of the breast cancer population. Morrell: Generally, the highly potent cancer genes such as BRCA are 'cancer syndrome' genes and have an increased risk of multiple cancers, such as the presence of pancreas and prostate cancer, might be a clue that there is a gene that also causes breast and ovarian cancer. Why are screening tests and personalized risk assessments important? Morrell: Most cancers remain unexplained by family history, but other factors can identify individuals who will benefit from screening tests. More importantly, a negative test for a well-known gene does not rule out the contribution of familial factors. The most common [misconception] is the belief that we will advise removal of the breasts for [the] BRCA [gene].